Euroapi S.A. (EAPIF)

Market Cap	367.64M
Revenue (ttm)	951.65M
Net Income (ttm)	-135.21M
Shares Out	n/a
EPS (ttm)	-1.43
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,449
Average Volume	2,010
Open	3.150
Previous Close	2.460
Day's Range	3.150 - 3.150
52-Week Range	2.460 - 4.800
Beta	0.65
RSI	40.97
Earnings Date	Jul 29, 2025

About Euroapi

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. The company provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. It offers their products to pharmaceutical, generic drug manufactu...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2020
• Employees: 3,187
• Stock Exchange: OTCMKTS
• Ticker Symbol: EAPIF

Financial Performance

In 2024, Euroapi's revenue was 919.20 million, a decrease of -9.79% compared to the previous year's 1.02 billion. Losses were -130.60 million, -31.15% less than in 2023.

Financial numbers in EUR